BUZZ-Innovent Biologics set for biggest jump in 5 months on FY revenue growth
Reuters03-27
BUZZ-<a href="https://laohu8.com/S/IVBIY">Innovent Biologics</a> set for biggest jump in 5 months on FY revenue growth
** Shares of Innovent Biologics Inc 1801.HK jump 7.7% to HK$85.55, on course for the biggest one-day pct rise since October 31
** Stock hit its highest level since March 17; sixth-largest pct gainer in the Hang Seng Biotech Index .HSBIO, which rises 3.8%
** The Chinese innovative medicines producer said its 2025 net profit amounted to 813.6 million yuan ($117.69 million), compared with a net loss of 94.6 million yuan in 2024, with revenue up 38.4% y/y at 13.04 billion yuan
** Citi maintains "Buy" on the stock and raises target price to HK$115 from HK$110, saying early stage differentiated candidates, including multiple next generation obesity assets, bispecific and others, could become a long-term growth engine
** YTD, stock up 10.1%
($1 = 6.9132 Chinese yuan renminbi)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments